Medsamic

Tranexamic Acid, the active ingredient in Medsamic, is an antifibrinolytic presented as an oral tablet for oral use. It reduces excessive bleeding in conditions such as heavy menstrual periods, nosebleeds, and surgical procedures, primarily in adult patients. GNH USA supplies Medsamic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tranexamic Acid is an antifibrinolytic used to control bleeding in several clinical settings. - Menorrhagia: decreases menstrual blood loss and improves quality of life. - Epistaxis: shortens duration and severity of nosebleeds. - Surgical bleeding: stabilises clot formation to reduce intra‑operative and post‑operative blood loss.

Tranexamic Acid is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes after dosing. - Diarrhoea: loose stools in some patients. - Abdominal pain: discomfort in the stomach area. - Headache: transient head pain. - Dizziness: feeling of light‑headedness.

Serious or Rare Side Effects: - Thromboembolic events: formation of abnormal clots in veins or arteries. - Visual disturbances: blurred vision or changes in colour perception. - Allergic reactions: rash, itching, or swelling. - Seizures: rare neurologic episodes. - Renal impairment: reduced kidney function in susceptible individuals. - Hypotension: sudden drop in blood pressure.

When prescribing Tranexamic Acid, clinicians should consider several safety measures. - Assess thrombotic risk: evaluate history of clotting disorders before use. - Monitor renal function: adjust use in patients with impaired kidney function. - Use caution in cardiovascular disease: patients with coronary artery disease may need closer observation. - Avoid in active intravascular clotting: contraindicated when clots are present. - Review concomitant anticoagulants: potential interaction may alter anticoagulant effect. - Store at room temperature: keep in the original pack, protect from moisture.

Tranexamic Acid can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Thrombolytic agents (e.g., alteplase): may counteract clot‑dissolving therapy and increase clot risk. - Oral anticoagulants (warfarin, DOACs): may diminish anticoagulant effectiveness and alter INR.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase bleeding tendency despite antifibrinolytic action. - Estrogen‑containing contraceptives: potential additive thrombotic risk. - Antihypertensives: monitor blood pressure as fluid shifts can occur.